American Vanguard (AVD)
Makes crop-protection, biological, and precision-application products for agricultural and non-crop markets.
Something off on this page? Send us feedback.
Sells synthetic, biological, and biorational products through AMVAC for U.S. crop, U.S. non-crop, and international markets. The business reports one segment, with economics shaped by acquired or licensed chemistries, direct international distribution, product regulation, and manufacturing-footprint changes.
Manufactures, formulates, packages, and sells specialty crop-protection and non-crop products through AMVAC. The portfolio spans Proven Chemistries, GreenSolutions biological and biorational products, and Precision Ag Technologies, including SmartBox+ and SIMPAS.
Serves U.S. crop and non-crop channels alongside international agricultural markets through subsidiaries and distributors in Latin America, Australia, New Zealand, India, and other territories. The business reports one operating segment, so product performance is managed through consolidated market opportunities rather than separate product-segment reporting.
Growth has depended on acquired and licensed chemistries, distribution expansion, and technical service in niche crop and non-crop markets. Product registrations, DCPA/Dacthal removal, and the Los Angeles manufacturing reset shape the current operating base.
Company facts
Target rangeAs of Sep 21, 2026
Latest analyst notes
No analyst notes in the last 24 months.
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $43.9M · Total debt $284.1M · Total assets $635.3M · Shareholders' equity $181.4M
- Revenue
- $116.8M
- Operating income
- −$303.0K
- Net income
- −$9.9M
HistoryDividendAnnual yield
| Institutions | 49.92% | 14.73M shares | |
|---|---|---|---|
| 106 holders · as of Jun 30, 2026 | |||
| Insiders | 3.59% | 1.06M shares | |
| 14 holders · as of Aug 20, 2026 | |||
| Other | 46.49% | 13.72M shares | |
| remainder | |||
29.50M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
T. Rowe Price Associates, Inc.Institution | 6.64% | 1.96M | filed Feb 14, 2020 |
Wellington Management Group LLPInstitution | 5.84% | 1.72M | as of Jun 30, 2026 |
Vanguard Capital Management LLCInstitution | 3.89% | 1.15M | as of Jun 30, 2026 |
BlackRock, Inc.Institution | 3.16% | 933,473 | as of Jun 30, 2026 |
Evr Research LPInstitution | 2.63% | 775,000 | as of Jun 30, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Aug 18, 2026 | Keith M. Rosenbloom | director | −556,580 | $2.20 |
| Aug 17, 2026 | Steven D. Macicek | director | +19,000 | $2.09 |
| Jun 3, 2026 | Douglas Kaye | officer: CHIEF EXECUTIVE OFFICER | +5,000 | $2.50 |
| May 12, 2026 | Patrick E. Gottschalk | director | +20,000 | $2.92 |
| May 13, 2026 | Patrick E. Gottschalk | director | +20,000 | $2.95 |
- FMC
Broad crop-protection rival across insecticides, herbicides, and biologicals
- Corteva
Large crop-protection platform overlapping in herbicides and biologicals
- Scotts Miracle-Gro
Non-crop rival in lawn, garden, weed, pest, and disease controls
- Deere & Company
Precision-application rival at the crop-protection delivery layer
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| American Vanguard | $2.10 | +1.70% | $58.9M | — | — | 0.1 | −9.7% |
| FMC | $10.69 | +3.94% | $1.29B | — | 7.6 | 0.4 | −17.5% |
| Corteva | $80.99 | +2.38% | $52.90B | 52.4 | 20.5 | 3.0 | −1.2% |
| Scotts Miracle-Gro | $53.15 | +3.35% | $2.99B | 44.7 | 11.7 | 0.9 | −1.3% |
| Deere & Company | $698.42 | +2.00% | $184.83B | 38.0 | 33.3 | 3.9 | +7.0% |
| Median | 44.7 | 16.1 | 1.9 | −1.3% |